Quantcast

Latest Morpholines Stories

2014-07-28 04:21:34

HILDEN, Germany and LONDON, July 28, 2014 /PRNewswire/ -- - Collaboration aims to create and commercialize companion diagnostic using genomic data from plasma samples to guide the use of IRESSA for non-small cell lung cancer patients - New blood test will build on QIAGEN's FDA-approved therascreen EGFR test and is planned to run on Rotor-Gene Q, member of the QIAsymphony family of automated instruments -...

2014-07-25 23:02:52

The Rottenstein Law Group, a national personal injury law firm, has launched a new website dedicated to providing the public information about the dangers of Xarelto and legal options if they have claims of harms suffered. Rockville Centre, NY (PRWEB) July 25, 2014 The Rottenstein Law Group LLP, a national personal injury law firm with over 25 years of experience advocating for plaintiffs with claims of harm stemming from dangerous prescription drugs, announces the launch of its new...

2014-07-23 12:31:37

However, Access Barriers Result in Greater Prescribing of Conventional Anticoagulants, According to Findings from Decision Resources Group BURLINGTON, Mass., July 23, 2014 /PRNewswire/ -- Decision Resources Group finds that novel oral anticoagulants (NOACs) such as Xarelto, Boehringer Ingelheim's Pradaxa and Bristol-Myers Squibb/Pfizer's Eliquis are preferred treatments for venous thromboembolism (VTE), atrial fibrillation (AF) and acute coronary syndrome (ACS) among physicians and payers in...

2014-07-17 23:04:20

Zoll, Kranz & Borgess, LLC, (ZKB), an experienced pharmaceutical and medical device litigation firm, is currently investigating claims of individuals who developed bleeding, clotting or other serious side effects or even death after taking the pharmaceutical drug, Xarelto® (rivaroxaban). Toledo, OH (PRWEB) July 17, 2014 Xarelto® (rivaroxaban) is an anticoagulant marketed in the U.S. by Janssen Pharmaceutical, a subsidiary of Johnson & Johnson. It is used to prevent blood...

2014-06-25 23:11:26

Several Xarelto users are considering filing a Xarelto lawsuit after suffering dangerous side effects associated with the popular blood thinner drug Xarelto (rivaroxaban). The Levin, Papantonio law firm has launched a Xarelto lawsuit website to assist those who have been injured from severe internal bleeding experienced after taking the blood thinner drug. Pensacola, FL (PRWEB) June 25, 2014 Users of the prescription drug Xarelto (rivaroxaban) are beginning to file Xarelto lawsuits after...

2014-06-10 12:29:47

Additional Novel Oral Anticoagulants are Expected to Gain Approval in China for AF and VTE in the Next Three to Four Years, According to Findings from Decision Resources Group BURLINGTON, Mass., June 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the high cost of therapy remains a significant barrier for uptake of novel oral anticoagulants (NOACs) in the Chinese market. Warfarin, the mainstay of anticoagulation treatment, is listed in the national essential drugs list and is...

2014-05-28 08:30:57

SAN DIEGO, May 28, 2014 /PRNewswire/ -- Ambit Biosciences (NASDAQ:AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Jefferies 2014 Global Healthcare Conference to be held at the Grand Hyatt Hotel in New York City on June 2-5, 2014. Michael Martino, Ambit's CEO, will provide an overview of the Company and its lead drug candidate,...

2014-05-19 23:11:24

Reliable Biopharmaceutical Corporation (RBC) announces the launch of cGMP MES Buffer. As regulations surrounding supply chain and excipient quality become more stringent, there is a need for high quality GMP commercial ingredient manufacturing. St. Louis, MO (PRWEB) May 19, 2014 cGMP MES Buffer is used in many critical processes by the biopharmaceutical industry. As regulations surrounding supply chain and excipient quality become more stringent, there is a need for high quality GMP...

2014-05-14 23:14:48

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) May 14, 2014 The drug safety advocates at DrugNews.net are alerting patients who have taken the anticoagulant Xarelto of new information on the site. A new report warns that the number of internal bleeding cases linked to the drug is steadily rising*. DrugNews is a free resource providing the latest product recalls, safety...

2014-05-06 16:33:03

Quizartinib QUANTUM-R Phase 3 Trial Begins SAN DIEGO, May 6, 2014 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced operating results for the first quarter 2014. The company will host a conference call today to discuss financial results for the first quarter, and to provide an update on plans and activities for 2014. "We...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related